On 25 February 2026, the EU General Court delivered a pivotal judgment in Case T-69/25 (A GmbH v Hauptzollamt C), resolving a long-standing dispute over the tariff classification of integrated dental amalgam capsules. This ruling provides a critical legal benchmark for any organization importing multi-component “kits” or “delivery systems” into the European Union.
Background and Legal Friction
A GmbH faced a challenge from German Customs authorities (the Hauptzollamt) regarding capsules containing separate chambers of silver alloy powder and liquid mercury. The authorities sought to “unbundle” the product, classifying the components individually under Chapters 28 and 71. Such a move typically exposes importers to higher revenue-generating duties or punitive Anti-Dumping Duties (ADD) on specific raw materials. A GmbH argued that the product must be classified as a single “Medical Set” (HS 3006) under the General Rules of Interpretation (GRI) 3(b) and Note 3 to Section VI of the Combined Nomenclature.
The Court’s Determination
The EU Court ruled in favour of the “Set” classification, emphasizing that the chambers are physically integrated and cannot be separated in a “non-destructive manner.” Because the components are presented together for the sole, unified purpose of creating a dental filling, they constitute a “functional unit.” This prevents authorities from arbitrarily deconstructing a product to extract higher taxes from its parts.
Business and Compliance Implications
- Audit Protection: This precedent serves as a robust “shield” against revenue-motivated audits where authorities attempt to deconstruct kits into higher-duty sub-components.
- Trade Defence Mitigation: It confirms that integrated systems can legally bypass ADDs that would otherwise apply to raw materials if imported as bulk chemicals.
- Classification Consistency: Compliance teams must ensure that “Set” classification is substantiated by Medical Device Regulation (MDR) documentation, as the customs benefit is intrinsically linked to the product’s intended medical utility.
The following is the official EU Court final ruling for Case T-69/25 (A GmbH v Hauptzollamt C):
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:62025TJ0069